Boosting with recombinant MVA expressing M. tuberculosis α-crystallin antigen augments the protection imparted by BCG against tuberculosis in guinea pigs.

about

Boosting with recombinant MVA expressing M. tuberculosis α-crystallin antigen augments the protection imparted by BCG against tuberculosis in guinea pigs.

Item

http://www.wikidata.org/entity/Q47155139

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Boosting with recombinant MVA ...... t tuberculosis in guinea pigs.

@en

Boosting with recombinant MVA ...... t tuberculosis in guinea pigs.

@nl

type

Item

label

Boosting with recombinant MVA ...... t tuberculosis in guinea pigs.

@en

Boosting with recombinant MVA ...... t tuberculosis in guinea pigs.

@nl

prefLabel

Boosting with recombinant MVA ...... t tuberculosis in guinea pigs.

@en

Boosting with recombinant MVA ...... t tuberculosis in guinea pigs.

@nl

P1476

Boosting with recombinant MVA ...... t tuberculosis in guinea pigs.

@en

P2093

Anil K Tyagi

http://www.w3.org/2001/XMLSchema#string

Prachi Nangpal

http://www.w3.org/2001/XMLSchema#string

Ritika Kar Bahal

http://www.w3.org/2001/XMLSchema#string

P2860

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin

Pre-clinical efficacy and safety of experimental vaccines based on non-replicating vaccinia vectors against yellow fever

A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations

MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses

Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis.

A booster vaccine expressing a latency-associated antigen augments BCG induced immunity and confers enhanced protection against tuberculosis.

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis

Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis.

Intradermal delivery of vaccines: potential benefits and current challenges.

P2888

s41598-017-17587-5

P304

17286

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-17587-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29230061

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium tuberculosis

P932

5725557

http://www.w3.org/2001/XMLSchema#string